Status:

WITHDRAWN

Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients

Lead Sponsor:

University of Minnesota

Conditions:

Auditory Hallucinations

Schizophrenia

Eligibility:

All Genders

18-45 years

Phase:

NA

Brief Summary

The overarching goal of this project is to expand the traditional expertise in non-invasive neuromodulation at the University of Minnesota towards developing novel neuromodulation approaches using tra...

Detailed Description

25% of schizophrenia (SZ) patients report chronic auditory hallucinations (AH) despite being on medication. Previous research proposed that hyperactivity of the left temporo-parietal cortex (11) and h...

Eligibility Criteria

Inclusion

  • Current DSM-V-defined diagnosis of SZ or Schizoaffective Disorder as assessed by the Structured Clinical Interview for Axis I DSM-V Disorders (SCID-I/P)
  • Ages 18-45
  • Competent and willing to sign consent form

Exclusion

  • Any serious neurological or endocrine disorder or any medical condition or treatment with neurological sequelae (i.e. stroke, tumor, loss of consciousness of more than 30 min, HIV)
  • Diagnostic and Statistics Manual (DSM-V) criteria for mental retardation or axis I psychiatric disorder, subjects may have a lifetime but not current diagnosis of depression
  • Primary current substance use disorder diagnosis on any substance except for caffeine or nicotine - nicotine use will be recorded but will not be an exclusion criterion
  • Medical condition which requires treatment with a medication with psychotropic effects
  • Significant risk of suicidal or homicidal behavior
  • Documented loss of consciousness (LOC) for longer than 30 minutes or LOC with neurological sequelae
  • History of electro-convulsive therapy
  • Pregnancy

Key Trial Info

Start Date :

June 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2018

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT02240446

Start Date

June 1 2013

End Date

December 1 2018

Last Update

July 20 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Minnesota

Minneapolis, Minnesota, United States, 55414

Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients | DecenTrialz